Nanotechnological approaches for pentamidine delivery

被引:14
作者
Andreana, Ilaria [1 ]
Bincoletto, Valeria [1 ]
Milla, Paola [1 ]
Dosio, Franco [1 ]
Stella, Barbara [1 ]
Arpicco, Silvia [1 ]
机构
[1] Univ Turin, Dept Drug Sci & Technol, Via P Giuria 9, I-10125 Turin, Italy
关键词
Pentamidine; Drug delivery; Liposomes; Nanoparticles; Repurposing; HUMAN AFRICAN TRYPANOSOMIASIS; LOADED POLY(D; L-LACTIDE); NANOPARTICLES; DRUG-DELIVERY; IN-VITRO; VISCERAL LEISHMANIASIS; PLGA; PHARMACOKINETICS; STRATEGIES; SYSTEM; BIODISTRIBUTION;
D O I
10.1007/s13346-022-01127-4
中图分类号
TH7 [仪器、仪表];
学科分类号
080401 [精密仪器及机械];
摘要
Pentamidine (PTM), which is a diamine that is widely known for its antimicrobial activity, is a very interesting drug whose mechanism of action is not fully understood. In recent years, PTM has been proposed as a novel potential drug candidate for the treatment of mental illnesses, myotonic dystrophy, diabetes, and tumors. Nevertheless, the systemic administration of PTM causes severe side effects, especially nephrotoxicity. In order to efficiently deliver PTM and reduce its side effects, several nanosystems that take advantage of the chemical characteristics of PTM, such as the presence of two positively charged amidine groups at physiological pH, have been proposed as useful delivery tools. Polymeric, lipidic, inorganic, and other types of nanocarriers have been reported in the literature for PTM delivery, and they are all in different development phases. The available approaches for the design of PTM nanoparticulate delivery systems are reported in this review, with a particular emphasis on formulation strategies and in vitro/in vivo applications. Furthermore, a critical view of the future developments of nanomedicine for PTM applications, based on recent repurposing studies, is provided.
引用
收藏
页码:1911 / 1927
页数:17
相关论文
共 145 条
[11]
Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases [J].
Babazadeh, Afshin ;
Vahed, Fereshteh Mohammadi ;
Jafari, Seid Mahdi .
JOURNAL OF CONTROLLED RELEASE, 2020, 321 :211-221
[12]
Drug delivery system: Targeting of pentamidines to specific sites using sugar grafted liposomes [J].
Banerjee, G ;
Nandi, G ;
Mahato, SB ;
Pakrashi, A ;
Basu, MK .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) :145-150
[13]
Stigmasterol as a potential biomarker for amphotericin B resistance in Leishmania donovani [J].
Bansal, Ruby ;
Sen, Shib Sankar ;
Muthuswami, Rohini ;
Madhubala, Rentala .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (04) :942-950
[14]
Advances in Development of New Treatment for Leishmaniasis [J].
Bezerra de Menezes, Juliana Perrone ;
Sampaio Guedes, Carlos Eduardo ;
de Oliveira Almeida Petersen, Antonio Luis ;
Mothe Fraga, Deborah Bittencourt ;
Tavares Veras, Patricia Sampaio .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[15]
Bilodeau M.S., 2016, HEPATOLOGY, V64, P136
[16]
PENTAMIDINE, AN INHIBITOR OF SPINAL FLEXOR REFLEXES IN RATS, IS A POTENT N-METHYL-D-ASPARTATE (NMDA) ANTAGONIST IN-VIVO [J].
BLOCK, F ;
SCHMITT, T ;
SCHWARZ, M .
NEUROSCIENCE LETTERS, 1993, 155 (02) :208-211
[17]
Human African Trypanosomiasis Progress and Stagnation [J].
Bottieau, Emmanuel ;
Clerinx, Jan .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2019, 33 (01) :61-+
[18]
Pentamidine uptake and resistance in pathogenic protozoa: past, present and future [J].
Bray, PG ;
Barrett, MP ;
Ward, SA ;
de Koning, HP .
TRENDS IN PARASITOLOGY, 2003, 19 (05) :232-239
[19]
Cyclodextrins as pharmaccutical solubilizers [J].
Brewster, Marcus E. ;
Loftsson, Thorsteinn .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :645-666
[20]
Human African trypanosomiasis [J].
Brun, Reto ;
Blum, Johannes ;
Chappuis, Francois ;
Burri, Christian .
LANCET, 2010, 375 (9709) :148-159